WeVote
Log In

Bill

Bill

AB 242

Genetic disease screening.

2025-2026 Regular Session Introduced by Tasha Boerner

AB 242 expands California's genetic disease screening for newborns and pregnant individuals to detect inherited conditions earlier, though funding mechanisms and program scope require appropriations committee approval.

In committee: Held under submission.
#geneticdiseasescreening
0
WeVote Research Nonpartisan
Bill Summary · AB 242

Legislative bill overview

AB 242 requires California to establish or expand genetic disease screening programs for newborns and pregnant individuals. The bill passed its health committee with unanimous support (15-0) and is currently in the appropriations committee, where it was placed on the consent calendar, indicating broad agreement on its merits.

Why is this important

Genetic screening can identify serious inherited conditions early enough for treatment or management, potentially preventing severe disability or death. The bill addresses whether California's current screening coverage is comprehensive enough and who should bear the cost of expanded testing.

Potential points of contention

  • Cost and funding: Expanded genetic screening programs require laboratory infrastructure and ongoing funding; the bill's fiscal impact and whether insurance or state budgets cover new tests remains unclear given its current appropriations committee status
  • Scope and access equity: Determining which genetic conditions warrant screening and ensuring equitable access across different populations and socioeconomic groups raises questions about resource allocation
  • Ethical and reproductive autonomy concerns: Prenatal genetic screening raises sensitive questions about disability, informed consent, and how results are communicated to parents

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.